Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-628-5 | CAS number: 108-90-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Demonstration of chlorobenzene-induced DNA demage in mouse lymphocytes using the single cell gel electrophoresis assay
- Author:
- Vaghef H & Hellman B
- Year:
- 1 995
- Bibliographic source:
- Toxicology 96, 19-28
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The DNA demaging effect of chlorobenzene was investigated in peripheral lymphocytes and bone marrow cells from female mice using a gel electrophoresis assay for DNA from single cells ("the single cell gel electrophoresis assay") under alkaline conditions. The effect of chlorobenzene was studied both after single and repeated intraperitoneal injections of chlorobenzene
- GLP compliance:
- not specified
- Type of assay:
- other: DNA damage using single cell gel electrophoresis
Test material
- Reference substance name:
- Chlorobenzene
- EC Number:
- 203-628-5
- EC Name:
- Chlorobenzene
- Cas Number:
- 108-90-7
- Molecular formula:
- C6H5Cl
- IUPAC Name:
- chlorobenzene
- Details on test material:
- - Name of test material (as cited in study report): chlorobenzene
- Analytical purity: no data
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- C57BL
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Alab, Solna, Sweden
- Weight at study initiation: 19-21 g
- Diet (e.g. ad libitum): standard pellet diet (EWOS AB, Södertälje, Sweden) ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23°C
- Photoperiod (hrs dark / hrs light): 12 hrs dark/12 hrs light
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: olive oil
- Duration of treatment / exposure:
- Single injection experiment: the duration of the exposure was 16 hours (from injection to sacrifice)
Repeated intraperitoneal injections experiment: the duration of the exposure was 3 days - Frequency of treatment:
- Repeated intraperitoneal injections experiment: daily
- Post exposure period:
- No post exposure period
Doses / concentrations
- Remarks:
- Doses / Concentrations:
750 mg/kg body weight
Basis:
nominal conc.
- No. of animals per sex per dose:
- Single dose experiment: 6 animals
Repeated dose experiment ( 3 days): 3 animals - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: intraperitoneal injection.
- Doses / concentrations: 150 mg /kg bw
- Justification for choice of positive control(s): cyclophosphamide is well known genotoxic cytostatic agent.
Examinations
- Tissues and cell types examined:
- Peripheral blood lymphocytes and bone marrow. cells
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Chlorobenzene was diluted in olive oil immediately before being injected intraperitoneally (i.p.), either as a single injection (750 mg/kg bw), or repeatedly for 3 days (3 x 750 mg/kg bw). The genotoxic agent cyclophosphamide, freashly dissolved in physiolological saline , was used as a reference substance to verify the sensitivity of the test system. Control animals received olive oil intraperitoneally , either as a single injection (10µl/g bw), or repeatedly with 24 hours between each injection (3 x 10 µl/g). The animals were killed in a CO2-saturated atmosphere 16 hours after the (last) injection. Blood samples and bone marrow cells were collected from each mouse and put on ice immediately after sacrifice. The whole study was divided into three separate experiments with seven mice in each (2 controls, 2 animals receving the reference substance and 3 mice given chlorobenzene).
DETAILS OF SLIDE PREPARATION: The single cells (peripheral lymphocytes and bone marrow cells) were analyzed under alkaline conditions. Dakin fully frosted microscope slides were initially covered with melted 0.6% normal melting agarose. A mixture of cells and agarose (75µl/slide) was pipetted onto pre-coated microscope slide. After application of a new coverslip, the slides were allow ed to gel on ice as above. The coverslip was removed, and a third layer of melted 0.5% low melting-point agarose (85µl/slide; 37°C) without cells, was gently applied as above. After removal of the coverslip, the cells were lysed and the microscope slides were placed in an electrophoresis unit. After the electrophoreis , the slides were carefully neutralized (2 times) with 0.4 M Trizma base for 5 minutes. After application of a coverslip, each slide was observed at 250 x magnification.
METHOD OF ANALYSIS:
A semiautomatic image system was used for quantitative evaluation of the DNA demage. A typical image, as observed in the fluorescence microscope, usually contains several objetcs looking like "comets". Each comet is built up by heavily stained cell nucleus ("comet head") with or without a less fluorescent " tail" of migrating genetic material, probably representing DNA-fragments. Cells with increased DNA demage display an increased migration of DNA-fragments from the nucleus towards the anode. The extent of demage in an individual cell can then be quantified by measuring various parameters of the displacement between the tail and the comet head.
Three different head parameters were calculated for each thresholded image: head size (the diameter of the cell nucleus in pixels); head area (the total area of the cell nucleus in pixels), and the head average intensity (the average absolute intensity of cell nucleus). For each tail, data was gathered on 1) total area; 2) average absolute intensity; and 3) distance to the center position of the head. The program gives: a) the tail leght; b) the tail average intensity of all tail lenght; c) the total tail area; d) the percentage of DNA in the comet (TDNA); e) the tail distance (TDx; the distance in x-direction between the center position of the head and the center gravity of the tail) ; and f) the tail moment (i.e., the torsional moment which is derived by multplying TDNA with TDx). All calculations were based on absolute intensities, and units for length are given as "number of pixels".
- Evaluation criteria:
- To judge whether a specific treatment induced DNA demage a two-by-two table was constructed by classifyng the cells from the controls and the treated animals as either "negative " or "positive". The 75 percentile for the tail moment in the vehicle-treated control group was used as a cut-off point were classifed as "positive", and those with lower tail moments as "negative". A similar analysis was made using the tail moment corresponding to the 95 percentile among the controls as an alternative cut-off point.
- Statistics:
- Statistical significance was judged using one-tailed Fisher´s exact test for two-by-two tables, testing the hypothesis that the number of cells with demaged DNA was increased in mice given cyclephosphamide or chlorobenzene. The Kruskall-Wallis one-way analysis of variance by ranks was used totest whether the distribution of various tail characteristics differed between individual groups with identical treatments in separate expetiments. The one-tailed Kolmogorov-Smirnow two samples test was used to test the hypothesis that the various tail parameters were increased in cell populations isolated from the cyclophosphamide and chlorobenzene-treated animals. These analyses were made for the entire cell populations. For comparative purposes, the various tail parameters were also analysed using the one-tailed t-test or indipedent samples.
Results and discussion
Test results
- Sex:
- female
- Genotoxicity:
- other: There was evidence of chlorobenzene-induced DNA damage after 3 days of repeated exposure in peripheral lymphocytes, but no indications of such an effect in bone marrow cells. Thus. high-dose exposure to chlorobenzene is associated with DNA damage
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
Any other information on results incl. tables
Table1 Percentage of peripheral lmphocytes and bone marrow cells with demaged DNA after administration of olive oil, ciclophosphamide or chlorobenzene.
Treatment | Cut-off point (percentile for tail moment among control) | Peripheral lymphocytes | Bone marrow cells | ||||
Percentage of "positive cells" | Increase in comparison to controls (percentage) | Percentage of "positive cells" | Increase in comparison to controls (percentage) | ||||
mean ± S.E | [95% CI] | mean ± S.E | [95% CI] | ||||
Controls | 95 | 5 | - | - | 5 | - | - |
olive oil | 75 | 25 | - | - | 25 | - | - |
Cyclophophamide | 95 | 67 *** | 62 ± 4 | [54 -70] | 14 ** | 9 ± 2 | [3 -14] |
150 mg/kg | 75 | 93 *** | 68 ± 5 | [59 -77] | 40 *** | 15 ±5 | [6 -24] |
Chlorobenzene | 95 | 5 | - | - | 3 | - | - |
1 x 750 mg/kg | 75 | 25 | - | - | 16 | - | - |
3 x 750 mg/kg | 95 | 14 *** | 8 ±2 | [4 -13] | 1 | - | - |
75 | 49 *** | 23 ± 4 | [15 -32] | 9 | - | - |
The results are presented as percentages of cells with tail moments exceeding the 75 and 95 percentiles for the tail moments among controls. The number of analyzed cells in each group varied between 180 and 360. For all groups of treatments, the viability of both the lymphocytes and bone marrow cells was over 95%. If a treatment was associated with an increase in the number of "positve" cells, the percentage of the mean increase +- S.E.M is given together with the 95 % confidence interval for the observed difference. Statistical signifcance was judged using the one-tailed Fisher´s exact test for two-by-two tables.
** P< 0.01; *** P < 0.001
Table 2 Tail parameters of peripheral lymphocytes and bone marrow cells from mice given olive oil, cyclophosphamide or chlorobenzene
Treatment | Cell Type | Tail lenght | Tail length/Head size | Percentage DNA in tail | Tail moment |
Mean +-SE (median) | Mean +-SE (median) | Mean +-SE (median) | Mean +-SE (median) | ||
Controls | Lymphocytes | 53 ± 3 (40) | 0.8 ± 0.03 (0.6) | 0.7 ± 0.05 (0.3) | 24 ± 2 (8) |
olive oil | Bone marrow cells | 76 ± 4 (58) | 1.1 ± 0.05 (0.8) | 2.4 ± 0.20 (1.4) | 105 ± 10 (44) |
Cyclophosphamide | Lymphocytes | 120 ± 4 ** (114) | 1.7 ± 0.06 ** (1.6) | 4.7 ± 0.24 ** (4.1) | 200 ± 12 ** (166) |
150 mg/kg | Bone marrow cells | 105 ± 3 ** (102) | 1.4 ± 0.04 ** (1.4) | 4.5 ± 0.27 ** (2.9) | 201 ± 15 ** (112) |
Chlorobenzene | Lymphocytes | 50 ±2 (37) | 0.7 ± 0.04 (0.5) | 0.6 ± 0.05 (0.2) | 21 ± 2 (4) |
1 x 750 mg /kg | Bone marrow cells | 70 ± 4 (48) | 1.0 ± 0.05 (0.8) | 1.9 ± 0.23 (0.6) | 79 ± 11 (23) |
3 x 750 mg/kg | Lymphocytes | 58 ± 3 * (48) | 0.8 ± 0.05 * (0.7) | 1.3 ± 0.13 ** (0.7) | 50 ± 5 ** (22) |
Bone marrow cells | 60 ± 3 (47) | 0.9 ± 0.04 (0.7) | 1.2 ± 0.12 (0.7) | 49 ± 6 (20) |
The results are presented as mean values ± SEM, together with the corresponding median values for 6 control mice; 6 mice given cyclphosphamide; 6 mice given a sdingle dose of chlorobenzene, and 3 mice given repeated injection of chlorobenzene. The number of analyzed cells varied between 180 and 360 in each group. For all treatments, the viability of both the lymphocytes and the bone marrow cells was over 95%. Statistical significances were judged using one-tailed Kolmogorov-smirnov two-sample test.
* P < 0.05; ** P < 0.001
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): positive
- Executive summary:
Vaghef & al., 1995.
The DNA damaging effect of chlorobenzene was investigated in peripheral lymphocytes and bone marrow cells from C57BL/6 female mice using a gel elctrophoresis assay for DNA from single cells ("the single cell gel electrophoresis assay") under alkaline conditions. The effect of chlorobenzene was studied both after single and repeated intraperitoneal injections of 750 mg/kg body weight in olive oil. The cytostatic agent cyclephosphamide (150 mg/kg, i.p) was used a reference substance, and vehicle-treated mice as controls. DNA demage was recorded 16 h after the (last) injection, using an automated computerized image analyses system specifically designed for the sinlge cell gel electrophoresis assay. There was evidence of chlorobenzene-induced DNA demage after 3 days of repeated exposure in peripheral lymphocytes, but no indications of such an affect in bone marrow cells. No effects were observed after single injection.
It is concluded that high-dose exposure to chlorobenzene is associated with genotoxicity to peripheral lymphocytes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.